Determining the true cost of laboratory-grade Cartalax (Ala-Glu-Asp) requires evaluating analytical purity, third-party validation, and manufacturing standards. PX1 Research provides fully documented, US-manufactured research peptides designed strictly for controlled in vitro and preclinical laboratory applications.
Determining the true cost of laboratory-grade Cartalax (Ala-Glu-Asp) requires evaluating analytical purity, third-party validation, and manufacturing standards. PX1 Research provides fully documented, US-manufactured research peptides designed strictly for controlled in vitro and preclinical laboratory applications.
When evaluating the Cartalax price for laboratory procurement, researchers must account for batch mass, analytical purity thresholds, synthesis quality, and the extent of third-party quality control. High-purity Cartalax (Ala-Glu-Asp) typically ranges in price based on milligram quantity, lyophilization protocols, and whether each lot includes comprehensive high-performance liquid chromatography (HPLC) and mass spectrometry (MS) documentation.
Cheaper unverified compounds frequently lack lot-specific Certificate of Analysis (COA) verification or exhibit high endotoxin levels that compromise in vitro assay validity. Investing in verified research-grade compounds ensures batch-to-batch consistency, minimizing experimental variance in cellular and tissue culture models. Procurement managers and principal investigators should evaluate suppliers based on cost-per-milligram ratios alongside analytical certification standard compliance.
Cartalax is a synthetic short peptide bioregulator consisting of three amino acids: L-alanine, L-glutamic acid, and L-aspartic acid (sequence: H-Ala-Glu-Asp-OH). Belonging to the class of peptide bioregulators pioneered by Khavinson and colleagues, Cartalax features a low molecular weight that facilitates cell membrane permeability in laboratory models.
In its purified form, Cartalax presents as a white, lyophilized powder with high solubility in aqueous solutions. Due to its defined tripeptide sequence, synthesis requires precise solid-phase peptide synthesis (SPPS) methods to prevent racemization or deletion sequences. When evaluating Cartalax for empirical work, verifying structural identity via mass spectrometry is critical prior to assay initiation.
Preclinical studies indicate that Cartalax plays a role in regulating chondrocyte gene expression and extracellular matrix (ECM) synthesis. In vitro models utilizing isolated primary chondrocytes demonstrate that exposure to short acidic tripeptides like Cartalax can modulate the expression of type II collagen and aggrecan, two vital structural components of articular cartilage.
Animal model studies investigating connective tissue degradation suggest that Cartalax may influence fibroblast proliferation and proteoglycan accumulation. Researchers studying musculoskeletal aging or degenerative joint models utilize Cartalax to observe epigenetic regulation at the chromatin level. Browse our research library for deeper insights into peptide bioregulator mechanisms and published experimental designs.
Understanding where Cartalax fits within the broader landscape of short peptide bioregulators and tissue-repair peptides helps researchers select the correct compound for their specific cell lineage assays. Cartalax (Ala-Glu-Asp) specifically targets cartilage and connective tissue dynamics, whereas other short peptides act upon distinct organ systems or cellular pathways.
For example, Vilon (Lys-Glu) is a synthetic dipeptide primarily investigated for its immunomodulatory effects and chromatin reactivation in immune cells. Similarly, Epitalon (Ala-Glu-Asp-Gly) is a tetrapeptide evaluated for its influence on telomerase activity and neuroendocrine regulation. In models focusing on systemic tissue repair and wound healing pathways, investigators often compare tripeptides like Cartalax to broader repair signals such as BPC-157. Selecting the appropriate compound depends on whether the study focuses on targeted cartilage gene expression or systemic cellular turnover.
Discrepancies in Cartalax pricing across vendors usually reflect differences in synthesis quality, facility accreditation, and testing transparency. Lower-cost suppliers often skip batch-level independent laboratory testing or ship unbuffered, raw synthesis products with variable moisture and salt contents.
In contrast, premium suppliers invest in ISO 17025 accredited third-party testing, ensuring that every batch achieves >98% purity by RP-HPLC and exhibits endotoxin levels below 0.01 EU/mg. Furthermore, US manufacturing under GMP-compliant conditions increases operational overhead but guarantees that researchers receive compounds free from heavy metal contamination, residual solvents, or unassigned peptide impurities. Evaluating price against these verification standards prevents costly experiment failures down the line.
To ensure that your Cartalax purchase meets rigorous scientific standards, researchers should inspect the lot-specific Certificate of Analysis. The COA must display clear analytical data, including Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) chromatograms and Electrospray Ionization Mass Spectrometry (ESI-MS) spectra.
The RP-HPLC chromatogram verifies chemical purity by measuring the peak area of Cartalax relative to secondary peaks. High-grade research material will show a primary peak representing >98% of total integrated area. ESI-MS confirms the exact molecular weight of the tripeptide, verifying sequence accuracy. Additionally, endotoxin testing via Limulus Amebocyte Lysate (LAL) assays confirms the absence of bacterial endotoxins that could skew sensitive cell culture experiments.
Proper handling and storage are essential to preserve the integrity of Cartalax and prevent peptide degradation. Lyophilized Cartalax should be stored at -20°C or -80°C upon arrival, shielded from light and ambient moisture. Under these conditions, the dry peptide remains stable for extended periods.
For laboratory reconstitution, researchers should reconstitute the cake using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream assay. Once reconstituted, solution aliquots should be prepared to avoid repeated freeze-thaw cycles, which can induce molecular cleavage. Reconstituted liquid aliquots should be maintained at -20°C and used within defined experimental timeframes.
In experimental setups targeting cartilage maintenance or chondrocyte differentiation, Cartalax is typically introduced to culture media in micromolar concentrations. Researchers measure parameters such as glycosaminoglycan (GAG) production, cell viability assays (MTT/CCK-8), and quantitative real-time PCR (qRT-PCR) tracking of matrix metalloproteinase (MMP) expressions.
In animal models, administration protocols vary based on study objectives, with investigators monitoring tissue histology, collagen density, and inflammatory biomarker expression. Standardizing working solution concentrations and documenting lot numbers ensures reproducibility across long-term experimental series. Explore our complete selection of research peptides to support comprehensive multi-compound assay designs.
Academic laboratories, biotechnology firms, and institutional research facilities often require larger quantities of Cartalax for high-throughput screening or multi-phase animal studies. Purchasing Cartalax in bulk quantities reduces the overall unit cost per milligram while ensuring single-lot consistency across all study arms.
PX1 Research offers structured institutional support, bulk tiered pricing, and dedicated account management for high-volume orders. To set up customized procurement arrangements, manage recurring shipments, or discuss large-scale research projects, researchers can explore our wholesale portal to speak directly with our supply chain team.
PX1 Research is dedicated to supplying the scientific community with fully validated, highly pure research compounds. Every lot of Cartalax synthesized in our GMP-compliant, US-based facilities undergoes rigorous independent third-party analytical testing. We provide accessible COAs featuring HPLC and MS verification for complete transparency.
To prevent project delays, PX1 Research provides same-day shipping on orders placed Monday through Friday from our California and Arizona distribution hubs. By pairing strict quality assurance with fast, reliable fulfillment, we ensure your laboratory receives research-grade peptides that meet the highest standards of analytical chemistry.
What factors influence the price of Cartalax for research?
Cartalax price is primarily determined by mass quantity (milligrams per vial), synthesis quality (>98% RP-HPLC purity), extent of third-party analytical testing (HPLC, MS, endotoxin levels), and manufacturing compliance standards.
Is Cartalax intended for human administration or clinical use?
No. Cartalax is supplied strictly as a research compound for laboratory in vitro and preclinical experimentation. It is not for human or animal consumption, medical treatment, or diagnostic use.
How can I verify the purity of my Cartalax lot?
Purity is verified by reviewing the lot-specific Certificate of Analysis (COA) supplied by PX1 Research. The COA includes RP-HPLC chromatograms showing purity levels and mass spectrometry confirming structural identity.
What is the recommended storage temperature for lyophilized Cartalax?
Lyophilized Cartalax should be stored at -20°C or -80°C in a desiccated environment protected from light to maintain long-term stability prior to reconstitution.
What solvent should be used for reconstituting Cartalax in the lab?
Cartalax is typically reconstituted in sterile bacteriostatic water, sterile normal saline, or sterile phosphate-buffered saline (PBS), depending on specific cell culture or assay protocols.
Are bulk discounts available for institutional Cartalax orders?
Yes. PX1 Research offers tiered pricing and custom sourcing options for institutional facilities and large volume laboratory requirements through our wholesale account portal.
What are the endotoxin limits for PX1 Research Cartalax?
All research peptides from PX1 Research, including Cartalax, are tested for endotoxins and maintain levels below 0.01 EU/mg to prevent interference in delicate biological assays.
Where does PX1 Research ship Cartalax from?
Cartalax orders ship directly from our US fulfillment centers located in California and Arizona, with same-day shipping available for orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.